Fuseau E - Search Results

1

Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation.

Marchand M, Fuseau E, Critchley DJ. Marchand M, et al. Among authors: fuseau e. J Pharmacokinet Pharmacodyn. 2010 Feb;37(1):99-118. doi: 10.1007/s10928-009-9146-4. J Pharmacokinet Pharmacodyn. 2010. PMID: 20084538

2

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E. Perucca E, et al. Among authors: fuseau e. Epilepsia. 2008 Jul;49(7):1123-41. doi: 10.1111/j.1528-1167.2008.01665.x. Epilepsia. 2008. PMID: 18503564 Free article.

3

Clinical pharmacokinetics of intranasal sumatriptan.

Fuseau E, Petricoul O, Moore KH, Barrow A, Ibbotson T. Fuseau E, et al. Clin Pharmacokinet. 2002;41(11):801-11. doi: 10.2165/00003088-200241110-00002. Clin Pharmacokinet. 2002. PMID: 12190330 Review.

4

Population pharmacokinetics of onercept in healthy subjects.

Glatt S, Fuseau E, Buraglio M, Nguyen QT. Glatt S, et al. Among authors: fuseau e. Clin Pharmacokinet. 2005;44(12):1295-304. doi: 10.2165/00003088-200544120-00008. Clin Pharmacokinet. 2005. PMID: 16372827 Clinical Trial.

5

Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.

Fabre MA, Fuseau E, Ficheux H. Fabre MA, et al. Among authors: fuseau e. J Pharm Sci. 2007 Dec;96(12):3444-56. doi: 10.1002/jps.21018. J Pharm Sci. 2007. PMID: 17854075 Clinical Trial.

6

Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine.

Fuseau E, Petricoul O, Sabin A, Pereira A, O'Quinn S, Thein S, Leibowitz M, Purdon H, McNeal S, Salonen R, Metz A, Coates P. Fuseau E, et al. Clin Ther. 2001 Feb;23(2):242-51. doi: 10.1016/s0149-2918(01)80006-0. Clin Ther. 2001. PMID: 11293557 Clinical Trial.

7

Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age- and body weight-related differences and consequences for dose adjustment in children.

Bellon A, Fuseau E, Roumanie O, Lamazure J, Stevens W, Dahmane A, Barthez-Toullec M, Golly D, Henriet C, Bridey F. Bellon A, et al. Among authors: fuseau e. Br J Clin Pharmacol. 2020 Feb;86(2):329-337. doi: 10.1111/bcp.14147. Epub 2020 Jan 9. Br J Clin Pharmacol. 2020. PMID: 31658379 Free PMC article.

8

Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders.

Thyssen A, Vermeulen A, Fuseau E, Fabre MA, Mannaert E. Thyssen A, et al. Among authors: fuseau e. Clin Pharmacokinet. 2010 Jul;49(7):465-78. doi: 10.2165/11531730-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20528007 Clinical Trial.

9

Pharmacokinetics and safety of roledumab, a novel human recombinant monoclonal anti-RhD antibody with an optimized Fc for improved engagement of FCγRIII, in healthy volunteers.

Yver A, Homery MC, Fuseau E, Guemas E, Dhainaut F, Quagliaroli D, Beliard R, Prost JF. Yver A, et al. Among authors: fuseau e. Vox Sang. 2012 Oct;103(3):213-22. doi: 10.1111/j.1423-0410.2012.01603.x. Epub 2012 May 8. Vox Sang. 2012. PMID: 22568808 Clinical Trial.

10

First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action.

Gueret P, Combe S, Krezel C, Fuseau E, van Giersbergen PL, Petitou M, Neuhart E. Gueret P, et al. Among authors: fuseau e. Eur J Clin Pharmacol. 2016 Sep;72(9):1041-50. doi: 10.1007/s00228-016-2077-2. Epub 2016 Jun 3. Eur J Clin Pharmacol. 2016. PMID: 27259709 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters